No Data
No Data
BetterLife Announces Intent to Complete Private Placement of Units
Express News | BetterLife Pharma Inc: Ind-Enabling Metabolism and Genotoxicity Glp Studies Have Been Initiated.
Express News | BetterLife Pharma Inc: Advanced in Ind-Enabling Studies for Betr-001, a Non-Hallucinogenic Derivative of Lsd
BetterLife Advances BETR-001 IND-enabling Studies
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF), an emerging biotech company focused on the development and commercialization of cutt
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enab...